000024991 000__ 01265cam\a2200445\i\4500
000024991 001__ 24991
000024991 003__ SzGeWIPO
000024991 005__ 20240708162121.0
000024991 008__ 071126s2009    enk|||||r|||| 00| 0 eng d
000024991 035__ $$a(wipo)0
000024991 035__ $$a(OCoLC)1158563795
000024991 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000024991 041__ $$aeng
000024991 043__ $$ae------
000024991 050_4 $$aK1501.2$$b.P38
000024991 08204 $$a346.0486$$220
000024991 084__ $$a53$$qGB
000024991 1001_ $$aCampolini, M.,$$eauthor.
000024991 24510 $$aViews on Europe's pharma patent system - R&D-based and generic industry positions /$$cM. Campolini.
000024991 264_1 $$aLondon [England] :$$bInforma Law,$$c2009.
000024991 300__ $$a1 volume ([2] pages) ;$$c[28] cm.
000024991 336__ $$atext$$btxt$$2rdacontent
000024991 337__ $$aunmediated$$bn$$2rdamedia
000024991 338__ $$avolume$$bnc$$2rdacarrier
000024991 4901_ $$aPatent World,$$x0950-2513 ;$$vGB 53 Feb 2009 No 209, pages 24-26
000024991 650_0 $$aPatent laws and legislation.
000024991 650_0 $$aPatents.
000024991 650_0 $$aTrademarks$$xLaw and legislation.
000024991 650_0 $$aComputer software$$vPatents.
000024991 650_0 $$aBiotechnology industries$$vPatents.
000024991 650_0 $$aIntellectual property.
000024991 650_0 $$aPatents$$zEurope.
000024991 650_4 $$aPharmaceutical Patents$$zEurope
000024991 650_4 $$aResearch & Development (R&D)
000024991 651_0 $$aEurope$$xCommerce$$xLaw and legislation.
000024991 830_0 $$aPatent World ;$$vGB 53 Feb 2009 No 209, pages 24-26.
000024991 903__ $$aPatent World.
000024991 904__ $$aJournal article
000024991 942__ $$cART$$jGB 53 Feb 2009 No 209$$2ddc
000024991 952__ $$w2009-02-19$$p2009-0229$$u38772$$bMAIN$$10$$kGB 53$$v2009-02-19$$70$$cMain Library$$yART
000024991 980__ $$aBIB
000024991 999__ $$c27304$$d27304